Longterm follow-up after transarterial chemotherapy for hepatocellular carcinoma in a Scandinavian centre.

Background: Transarterial chemotherapy infusion (TAI) with lipiodol is a palliative treatment for hepatocellular carcinoma. The aim of this study was to describe the outcomes of TAI from a single scandinavian centre between 1995 to 2008.

Methods: The study is a retrospective analyse of prospectively collected data.